Product Publications

SomatoRel^® (Somatropin)

Comparative study to evaluate efficacy, safety and pharmacokinetics of first indigenous biosimilar somatropin. International Journal of Current science and technology. Vol.7, Issue 3(A): 763-767, March 2019. know more...

Reliseal^® (Fibrin Sealant)

Successful use of fibrin sealant in post-catheterization pseudo-aneurysm of femoral artery after failure of compression attempt – a case study. International Journal of Current Research. Vol. 11, Issue 01: 711-714, January, 2019. know more...

PegReligrast^® (Pegfilgrastim)

Randomised, multicentric, double blind comparative study to evaluate efficacy and safety of biosimilar pegfilgrastim and reference pegfilgrastim in patients with chemotherapy induced neutropenia (CIN). International Journal of Current Research. Vol. 10, Issue 10: 74013-74018, October 2018. know more...

Infliximab

Comparative Study for Efficacy and Safety of Biosimilar Infliximab in Patients with Active Rheumatoid Arthritis on a stable Dose of Methotrexate. Journal of Arthritis & Rheumatology Research., volume 1 (1): June 2018. know more...

AdaliRel^® (Adalimumab)

A Prospective, Randomized, Double blind, Comparative Clinical Study of Efficacy and Safety of a Biosimilar Adalimumab with Innovator Product in Patients with Active Rheumatoid Arthritis on a Stable Dose of Methotrexate. Indian Journal of Rheumatology. Volume 13 (2): 84-89, March 2018. know more...

DarbeRel^® (Darbepoetin)

Comparative Efficacy and Safety of Biosimilar Darbepoetin Alfa in Adults with Anemia of Chronic Kidney Disease. Indian Journal of Transplantation. Volume 12 (1): 30-34, January-March 2018. know more...

TrastuRel^® (Trastuzumab)

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel^® (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer. Indian Journal of Cancer.; Volume 54 (4): 664-8, October-December 2017. know more...

BevaciRel^® (Bevacizumab)

Comparative pharmacokinetics, efficacy and safety of bevacizumab biosimilar to reference bevacizumab in patients with metastatic colorectal cancer. Indian Journal of Cancer. Volume 54 (3): 535-538, September 2017. know more...

MIRel^® (Reteplase) 2

Thrombolysis with Reteplase in the Management of ST-Elevation in Myocardial Infarction and Evaluation of Patients in a Primary Care Setup (TRIME Study). Indian Medical Gazette. 207-212, July 2017. know more...

RituxiRel^® (Rituximab)

A phase III, multicentric, open label, two arm, parallel group, active control, randomized, comparative clinical study to evaluate efficacy and safety of RituxiRel^® arm (rituximab) with reference rituximab in patients with non Hodgkin’s Lymphoma. Asian Journal of Oncology. Volume 3 (1): 17-22, Jan-June 2017. know more...

MIRel^® (Reteplase) 1

Clinical Retrospective and Prospective Evaluation of Efficacy and Safety of Reteplase in STEMI Patient. Indian Medical Gazette. 479-487, Dec 2012. know more...

Relipoietin^® (Erythropoietin)

Efficacy of Single Dose (Once Weekly Administration) of Recombinant Human Erythropoietin “ReliPoietin^®” in Patients of CKD (Chronic Kidney Disease) with Anemia. Indian Medical Gazette. 1-6, July 2011. know more...